Estée Lauder Companies Stock EL
Estée Lauder Companies stock (EL): Quarterly and annual results since 2023 from Quarterly Report and SEC filings: revenue, earnings, balance sheet, cash flow and management guidance, every figure with its source. As of 08/2026, quarterly reporting. Stock analysis by NadirAlpha. Estée Lauder Companies stock (EL): listed on NYSE, index S&P 500, WKN 897933. NadirAlpha has evaluated 48 original documents, cross-checked every figure automatically and linked each to its source; sources as of 08/2026. Revenue Q4 FY2026 (Apr to Jun 2026): USD 3.6 billion (+6% year on year). Latest reading: Operating income turned positive, Guidance initiated, Net income turned positive.
AI-generated report · not investment advice · figures extracted automatically; please verify against the linked original more
Estée Lauder Companies Current Status
The current state of Estée Lauder Companies at a glance, figures as of Q4 FY2026, with core figures and the key management statements from the latest filing. NadirAlpha methodology
Assessment by NadirAlpha, as of Q4 FY2026 (Apr to Jun 2026).
“For fiscal 2027, we are affirming our confidence to accelerate organic sales growth. In addition, we are raising our outlook for an even stronger adjusted operating margin, as we double down on our strengths to further diversify growth across product categories and geographies, including accelerating growth in North America.”
“I am incredibly proud of our team for delivering fiscal 2026 results ahead of the expectations we had to start the year. We reignited growth with organic sales rising 3%, driven by the breadth of growth across brands, and achieved significant operating margin expansion. We ended the year on a high note, as organic sales growth accelerated to 5% for our fourth consecutive quarter of growth and stronger profitability. We are delivering on all aspects of Beauty Reimagined. Our One ELC operating model is increasingly enabling the entire organization to move at speed and with discipline.”
Estée Lauder Companies Stock: Key Figures ($ million)
NadirAlpha shows fiscal years, half-years and quarters of Estée Lauder Companies one below the other, most recently Q4 FY2026; every figure is clickable and leads to raw value, location and source. NadirAlpha extracts all values automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original. NadirAlpha methodology
All figures serve only to support your own investment decision and are not a recommendation; the company's original reports are authoritative.
Fiscal years
| Period | Calendar quarter | Revenue | Op. income | Op. income (adj.) | EPS ($) | EPS adj. ($) | OCF | Source |
|---|---|---|---|---|---|---|---|---|
| FY2026 | Q3/2025–Q2/2026 | 15,049 | 780 | 1,687 | 0.50 | – | 1,773 | 30 |
| FY2025 | Q3/2024–Q2/2025 | 14,326 | -785 | 1,146 | -3.15 | – | 1,272 | 21 |
| FY2024 | Q3/2023–Q2/2024 | 15,608 | 970 | 1,588 | 1.08 | 2.59 | 2,360 | 13 |
Quarters
| Period | Calendar quarter | Published | Revenue | Op. income | Op. income (adj.) | Net income | EPS ($) | EPS adj. ($) | FCF | Cash | Net Debt | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-Q4* | Q2/2026 | 2026-08-19 | 3,627 | -39 | 267 | -116 | -0.31*≈ | – | 425 | 3,498 | 3,808 | 130 |
| 2026-Q3* | Q1/2026 | 2026-05-01 | 3,712 | 249 | 557 | 89 | 0.24 | – | 310 | 3,126 | 4,186 | 27 |
| 2026-Q2* | Q4/2025 | 2026-02-05 | 4,229 | 401 | 608 | 162 | 0.44 | – | 1,017 | 3,082 | 4,237~ | 25 |
| 2026-Q1* | Q3/2025 | 2025-10-30 | 3,481 | 169 | 255 | 47 | 0.13 | – | -436 | 2,219 | 5,101~ | 23 |
| 2025-Q4* | Q2/2025 | 2025-08-20 | 3,411 | -390 | 137 | -546 | -1.52*≈ | – | 394 | 2,921 | 4,396 | 21 |
| 2025-Q3* | Q1/2025 | 2025-05-01 | 3,550 | 306 | 403 | 159 | 0.44 | – | 162 | 2,631 | 4,667~ | 19 |
| 2025-Q2* | Q4/2024 | 2025-02-04 | 4,004 | -580 | 462 | -590 | -1.64 | – | 925 | 2,586 | 4,690~ | 17 |
| 2025-Q1* | Q3/2024 | 2024-10-31 | 3,361 | -121 | 144 | -156 | -0.43 | 14.00 | -811 | 2,350 | 5,465 | 15 |
| 2024-Q4* | Q2/2024 | 2024-08-19 | 3,871 | -233 | 349 | -284 | -0.79*≈ | 0.64 | 672 | 3,395 | 4,376 | 114 |
| 2024-Q3* | Q1/2024 | 2024-05-01 | 3,940 | 531 | 554 | 330 | 0.91 | 1.02 | 359 | 3,701 | 4,069 | 11 |
| 2024-Q2* | Q4/2023 | 2024-02-05 | 4,279 | 574 | 577 | 313 | 0.87 | 0.89 | 1,113 | 3,939 | 4,201 | 9 |
| 2024-Q1* | Q3/2023 | 2023-11-01 | 3,518 | 98 | 108 | 31 | 0.09 | 0.11 | -703 | 3,090 | 5,003 | 7 |
Estée Lauder Companies Balance Sheet & Cash Flow ($ million)
NadirAlpha places cash, debt, operating cash flow and investments of Estée Lauder Companies side by side per period, balance sheet values as of the period end, flow items for the period. NadirAlpha extracts all values automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original. NadirAlpha methodology
Fiscal years
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 | Q3/2025–Q2/2026 | 2026-08-19 | 3,498 | 7,306 | 3,808 | 796 | 1,773 | 457 | 1,316 | 29 |
| FY2025 | Q3/2024–Q2/2025 | 2025-08-20 | 2,921 | 7,317 | 4,396 | 829 | 1,272 | 602 | 670 | 21 |
| FY2024 | Q3/2023–Q2/2024 | 2024-08-19 | 3,395 | 7,771 | 4,376 | 825 | 2,360 | 919 | 1,441 | 13 |
Quarters
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-Q4 | Q2/2026 | 2026-08-19 | 3,498 | 7,306 | 3,808 | 198 | 576 | 151 | 425 | 130 |
| 2026-Q3 | Q1/2026 | 2026-05-01 | 3,126 | 7,312 | 4,186 | 201 | 412 | 102 | 310 | 27 |
| 2026-Q2 | Q4/2025 | 2026-02-05 | 3,082 | 7,319~ | 4,237~ | 197 | 1,125 | 108 | 1,017 | 25 |
| 2026-Q1 | Q3/2025 | 2025-10-30 | 2,219 | 7,320~ | 5,101~ | 200 | -340 | 96 | -436 | 23 |
| 2025-Q4 | Q2/2025 | 2025-08-20 | 2,921 | 7,317 | 4,396 | 210 | 601 | 207 | 394 | 21 |
| 2025-Q3 | Q1/2025 | 2025-05-01 | 2,631 | 7,298~ | 4,667~ | 204 | 284 | 122 | 162 | 19 |
| 2025-Q2 | Q4/2024 | 2025-02-04 | 2,586 | 7,276~ | 4,690~ | 207 | 1,057 | 132 | 925 | 17 |
| 2025-Q1 | Q3/2024 | 2024-10-31 | 2,350 | 7,815 | 5,465 | 208 | -670 | 141 | -811 | 15 |
| 2024-Q4 | Q2/2024 | 2024-08-19 | 3,395 | 7,771 | 4,376 | 211 | 889 | 217 | 672 | 114 |
| 2024-Q3 | Q1/2024 | 2024-05-01 | 3,701 | 7,770 | 4,069 | 206 | 534 | 175 | 359 | 11 |
| 2024-Q2 | Q4/2023 | 2024-02-05 | 3,939 | 8,140 | 4,201 | 205 | 1,345 | 232 | 1,113 | 9 |
| 2024-Q1 | Q3/2023 | 2023-11-01 | 3,090 | 8,093 | 5,003 | 203 | -408 | 295 | -703 | 7 |
Estée Lauder Companies Guidance Tracking (latest per metric/period · 24/39)
All forecasts (guidance) of the Estée Lauder Companies management and their later outcome: per metric and period the most recent statement applies, the status is checked against the reported actuals. NadirAlpha methodology
Actuals: EPS in $ per share · ratios in %
Direction: affirmedconfirmedcutinitiatedraised Verdict: beatin linemisspending
| For period | Guided on | Metric | Guided | Actual | Verdict | Direction | Source |
|---|---|---|---|---|---|---|---|
| FY2027 | 2026-08-19 | Tax rate | 33–34% | – | 30 | ||
| FY2027 | 2026-08-19 | Operating margin | 12.7–13.5% | – | 30 | ||
| FY2027 | 2026-08-19 | Organic Net Sales Growth | 3–5% | – | 30 | ||
| FY2026 | 2026-02-05 | EPS (non-GAAP) | 1.03–1.07 | – | – | 26 | |
| FY2026 | 2026-02-05 | Tax rate | ~36% | – | – | 26 | |
| FY2026 | 2026-02-05 | Operating margin | 9.8–10.2% | 5.2 | 26 | ||
| FY2026 | 2026-02-05 | Organic net sales growth | 1–3% | – | – | 26 | |
| FY2026 | 2025-08-20 | Organic Net Sales | 2–5% | – | – | 22 | |
| FY2026 | 2025-08-20 | Net Cash Flows Provided by Operating Activities | 1,000–1,100 | – | – | 22 | |
| FY2025 | 2025-05-01 | Gross margin (non-GAAP) | ~73.5% | – | – | 20 | |
| FY2025 | 2025-05-01 | EPS (non-GAAP) | .94 - .97 | – | – | – | 20 |
| FY2025 | 2025-05-01 | Tax rate | ~38% | – | – | 20 | |
| FY2025 | 2025-05-01 | Organic Net Sales, Non-GAAP | 8–9% | – | – | 20 | |
| FY2025 | 2024-08-19 | EPS (GAAP) | 2.52–2.76 | -3.15 | 14 | ||
| FY2025 | 2024-08-19 | Operating margin | 11–11.5% | -5.5 | 14 | ||
| FY2025 | 2024-08-19 | Reported and Organic Net Sales | 1–2% | – | – | 14 | |
| 2025-Q3 | 2025-02-04 | EPS (non-GAAP) | .13 - .16 | – | – | 18 | |
| 2025-Q3 | 2025-02-04 | Organic Net Sales | 10–12% | – | – | 18 | |
| 2025-Q2 | 2024-10-31 | EPS (GAAP) | .02 - .19 | -1.64 | – | – | 16 |
| 2025-Q2 | 2024-10-31 | EPS (non-GAAP) | .20 - .35 | – | – | 16 | |
| 2025-Q2 | 2024-10-31 | Reported and Organic Net Sales | 6–8% | – | – | – | 16 |
| 2025-Q1 | 2024-08-19 | EPS (GAAP) | -0.09 | -0.43 | 14 | ||
| 2025-Q1 | 2024-08-19 | EPS (non-GAAP) | 0.01–0.09 | 14 | – | 14 | |
| 2025-Q1 | 2024-08-19 | Reported and Organic Net Sales | 3–5% | – | – | 14 | |
| FY2024 | 2023-11-01 | EPS (GAAP) | 2.08–2.35 | 1.08 | 8 | ||
| FY2024 | 2023-11-01 | EPS (non-GAAP) | 25–33% | 2.59 | – | 8 | |
| FY2024 | 2023-11-01 | Revenue growth (YoY) | 1–2% | -1.9 | 8 | ||
| FY2024 | 2023-11-01 | Organic Net Sales | 1–2% | – | – | 8 | |
| 2024-Q4 | 2024-05-01 | EPS (GAAP) | $.11 - $.22 | -0.79 | – | 12 | |
| 2024-Q4 | 2024-05-01 | EPS (non-GAAP) | $.18 - $.28 | 0.64 | – | 12 | |
| 2024-Q4 | 2024-05-01 | Revenue growth (YoY) | 5–9% | 7.3 | 12 | ||
| 2024-Q4 | 2024-05-01 | Organic Net Sales | 6–10% | – | – | 12 | |
| 2024-Q2 | 2023-11-01 | EPS (GAAP) | between $.47 and $.57 | 0.87 | – | 8 | |
| 2024-Q2 | 2023-11-01 | EPS (non-GAAP) | between $.48 and $.58 | 0.89 | – | 8 | |
| 2024-Q2 | 2023-11-01 | Revenue growth (YoY) | 9–11% | -7.4 | 8 | ||
| 2024-Q2 | 2023-11-01 | Organic Net Sales | 8–10% | – | – | 8 | |
| 2024-Q1 | 2023-08-18 | EPS (GAAP) | -0.34–-0.23 | 0.09 | 6 | ||
| 2024-Q1 | 2023-08-18 | EPS (non-GAAP) | -0.29–-0.19 | 0.11 | 6 | ||
| 2024-Q1 | 2023-08-18 | Q1 FY2024 Reported and Organic Net Sales | -12–-10% | – | – | 6 |
Estée Lauder Companies Stock: Price & Chart
Chart and key figure trend of Estée Lauder Companies stock: the TradingView chart starts only on click, the key figure chart comes from the core tables up to Q4 FY2026. NadirAlpha methodology
Daily candles with news and earnings markers. Loads only on click.
Estée Lauder Companies Event Timeline
NadirAlpha sorts 45 events of Estée Lauder Companies by quarter, most recent first, each with source number and event type, management quotes as direct quotes at the start of the quarter. NadirAlpha methodology
2026 · 14 events
Operating income of USD 780 million vs. prior-year operating loss of $785 million, primarily from favorable comparison to prior-year impairment charges and increased sales 29
FY2027 initial outlook: organic net sales growth of 3% to 5% with adjusted operating margin raised to 12.7% to 13.5% 30
Operating income turned positive for the first time after 1 negative fiscal year (-785.0 to +USD 780.0 million). 30
“Fiscal 2026 is promising to be the pivotal year we intended, one in which we restore organic sales growth and expand our adjusted operating margin for the first time in four years. Looking ahead to fiscal 2027, we are confident in our improving trajectory and realizing the benefits of One ELC, especially its One Operating Ecosystem which will be fully deployed. Our preliminary view is to accelerate organic sales growth and for adjusted operating margin to approach 13%, albeit in an uncertain geopolitical and macroeconomic environment.”
Adjusted operating margin expanded 360 basis points to 15.0% from 11.4% in the prior-year quarter, driven by gross margin expansion and operating leverage 28
Restructuring program expanded to an estimated net reduction of 9,000 to 10,000 positions globally with expected annual gross benefits of $1,000 million to $1,200 million before taxes 27
Forest Essentials acquisition agreement announced in March 2026, subject to regulatory approvals 28
“We delivered excellent second quarter results to solidify a strong first half of fiscal 2026. In this pivotal year, Beauty Reimagined has invigorated our business as we execute the biggest operational, leadership, and cultural transformation in our history. On its one-year anniversary, we raise our fiscal 2026 outlook confident in the strength of our turnaround, even as our second half reflects previously-expected headwinds and now-greater consumer-facing investments, as we expect to restore organic sales growth and expand our operating margin for the first time in four years.”
Net sales of USD 4,229 million increased 6%, with Mainland China growing 13% for a second consecutive quarter of double-digit retail sales growth 25 26
Adjusted operating margin expanded 290 basis points to 14.4% from 11.5%, reflecting net benefits from the Profit Recovery and Growth Plan 26
Full-year FY2026 outlook raised for organic net sales growth, adjusted operating margin, and adjusted diluted EPS 26
“We had a strong start to fiscal 2026 as we execute on our Beauty Reimagined strategy–returning to organic sales growth, gaining prestige beauty share in a few key strategic areas of focus, and improving profitability. Encouragingly, we are building momentum across the organization from the significant operational changes we have executed to-date to be faster and more agile. These results reinforce the confidence we have in our fiscal 2026 outlook–a pivotal year–as we restore organic sales growth and expand our operating margin for the first time in four years.”
Operating income of USD 169 million vs. prior-year loss, primarily due to prior-year talcum litigation settlement charges not recurring in the current period 23
Adjusted operating margin expanded 300 basis points to 7.3% from 4.3%, driven by gross margin improvement and PRGP operational efficiencies 24
Beauty Reimagined initiative launched and Profit Recovery and Growth Plan restructuring program expanded to an estimated net reduction of 5,800 to 7,000 positions globally, targeting annual gross benefits of $800 million to $1,000 million before taxes 23
2025 · 16 events
“Having closed fiscal 2025 as expected, we remain wholly focused on continuing to execute our strategic vision of Beauty Reimagined with excellence. Despite continued volatility in the external environment, we embarked on fiscal 2026 with signs of momentum and confidence in our outlook to deliver organic sales growth this year after three years of declines and to begin rebuilding operating profitability in pursuit of a solid double-digit adjusted operating margin over the next few years.”
$375 million Dr.Jart+ asset impairment recorded in fiscal 2025 following interim impairment review triggered in April 2025 21
FY2026 outlook affirms return to positive organic sales growth of 2% to 5% and adjusted operating margin of 9.4% to 9.9% 22
Beginning FY2026 first quarter, Estée Lauder will report under a new four-region geographic structure 22
“In the third quarter of fiscal 2025, we delivered our organic sales outlook and exceeded profitability expectations. We are moving decisively and building momentum as we bring our "Beauty Reimagined" strategic vision to life across its five key priorities. This is evidenced by our prestige beauty share gains in strategic markets like the U.S., China, and Japan and our mid single-digit organic net sales growth online.”
Net sales decreased 10% to USD 3,550 million; organic net sales decreased 9%, driven by volume declines across all product categories and geographic regions 20
Adjusted operating margin contracted 270 basis points to 11.4% from 14.1%, reflecting volume deleverage and increased consumer-facing investments 20
Strategic partnership with Adobe announced in March 2025 to integrate Firefly generative AI into Creative Cloud workflows 20
Operating income turned positive for the first time after 3 negative periods (-580.0 to +USD 306.0 million). 19
Net income turned positive for the first time after 3 negative periods (-590.0 to +USD 159.0 million). 19
“In order to reignite our retail sales growth, we are strategically increasing consumer-facing investments around the world in the third quarter. We expect the benefits of the PRGP to both fund these investments and modestly offset the meaningful operating deleverage from the sales decline.”
Operating loss of USD 580 million including $861 million in goodwill and intangible asset impairments for TOM FORD and Too Faced brands 17
Gross margin expanded 310 basis points to 76.1%, driven by lower obsolescence charges and manufacturing cost efficiencies 17
Beauty Reimagined strategic vision launched; Profit Recovery and Growth Plan expanded to 5,800 to 7,000 position reductions with estimated charges of $1.2 billion to $1.6 billion 18
Operating loss of USD 121 million versus $98 million income in the prior year, impacted by $106 million restructuring charges and $159 million talcum litigation settlement 15
Gross margin increased to 72.4% from 69.6%, benefiting from lower obsolescence charges and manufacturing cost favorability 15
Restructuring program announced targeting 1,800 to 3,000 position reductions with expected charges of $500 million to $700 million 15
2024 · 15 events
“In fiscal 2024's fourth quarter, we achieved our organic sales outlook and exceeded expectations for profitability, closing a difficult year. Organic sales and adjusted EPS returned to growth in the second half.”
Q4 reported an operating loss of 233 million, primarily driven by $471 million in goodwill and other intangible asset impairments related to the Dr.Jart+ reporting unit, which reflected lower-than-expected growth and a strategic decision to exit travel retail 14 13
Full acquisition of DECIEM Beauty Group Inc. completed in May 2024 for $859 million, bringing ownership to 100% 14
“With our third quarter results and fourth quarter outlook, we are confident that the second half of fiscal 2024 will prove to be an inflection point for our Company performance. We expect accelerating momentum in organic sales growth in the fourth quarter, and for operating margin in the second half of fiscal 2024 to not only be stronger than the first half but also to expand from the year-ago period.”
Net sales increased 5% to 3,940 million; organic net sales grew 6%, driven by double-digit growth in EMEA and recovery in the Asia travel retail channel 12
Gross margin expanded 280 basis points to 71.9% from 69.1%, driven by favorable business mix, reduction in obsolescence charges, and strategic pricing; operating income increased 79% to 531 million 11 12
Full-year fiscal 2024 organic net sales guidance reduced to (2%) to (1%) and adjusted diluted EPS guidance revised to $2.14 to $2.24, with an inflection in profitability in the second half expected 12
Net income more than doubled YoY (156.0 to USD 330.0 million, +112%). 11
Operating cash flow reached USD 534.0 million vs USD 266.0 million in 2023-Q3 (×2.0). 11
“For the second quarter of fiscal 2024, we delivered our organic sales outlook and exceeded expectations for profitability. The Ordinary and La Mer in Skin Care, Clinique in Makeup, and Le Labo and Jo Malone London in Fragrance performed strongly. Many developed and emerging markets around the world continued to grow organically and at retail. While mainland China and Asia travel retail declined, our retail sales trended ahead of organic sales, and these businesses are poised to return to organic sales growth in the second half.”
Organic net sales declined 8% in Q2, with EMEA net sales declining 13% driven by Asia travel retail inventory reset and continued mainland China prestige beauty softness 10 9
Full-year fiscal 2024 outlook revised: organic net sales guidance tightened to flat to 1% growth and adjusted diluted EPS lowered to $2.08 to $2.23 10
Profit Recovery Plan launched November 1, 2023 with a restructuring program targeting 1,800 to 3,000 position reductions globally, estimated charges of $500 to $700 million, and annual gross benefits of $350 to $500 million before taxes 9
“In the context of a quarter which we anticipated to be challenging, we delivered our organic sales outlook and exceeded expectations for profitability. Momentum continued in many developed and emerging markets around the world, where our organic sales grew strongly and we realized prestige beauty share gains. Encouragingly, we returned to growth in the U.S., with Fragrance, Makeup and Skin Care all contributing. This performance partially offset the pressures of Asia travel retail and a slower recovery of overall prestige beauty in mainland China.”
“Our first quarter results are largely aligned with our outlook on an adjusted basis, despite the fact that the expected headwinds in China and Asia travel retail were greater than anticipated. Our Profit Recovery and Growth Plan drove gross margin expansion, which was partially offset by operating deleverage. Other pillars of our strategic reset also delivered promising initial results.”
Cybersecurity incident disclosed July 2023 impacted operations and was dilutive to Q1 earnings per share by $0.08 8
Net sales declined 10% to 3,518 million, driven primarily by a 13% decrease in volume as Asia travel retail faced a retailer inventory reset and mainland China prestige beauty recovery slowed 7
Company lowered full-year fiscal 2024 outlook citing incremental external headwinds 8
Operating income more than halved YoY (661.0 to USD 98.0 million, -85%). 7
Estée Lauder Companies Business Model
How Estée Lauder Companies (EL) makes its money, summarised from the filings up to Q4 FY2026, neutral and without forecast. NadirAlpha methodology
Estée Lauder is a multinational prestige beauty company that develops, manufactures, markets, and sells skincare, makeup, fragrance, and hair care products under a portfolio of brands including Estée Lauder, La Mer, Clinique, MAC, Jo Malone London, TOM FORD, Le Labo, KILIAN PARIS, The Ordinary, and others across approximately 150 countries and territories. Revenue is generated through department stores, specialty-multi retailers, company-operated freestanding stores and salons, e-commerce platforms, and travel retail, with product sales organized across four reported segments: Skin Care, Makeup, Fragrance, and Hair Care. Estée Lauder Companies earns primarily through direct brand ownership, with Skin Care representing the largest segment by net sales, operating across multiple price tiers within the prestige beauty market.
Estée Lauder Companies Stock: Share-Price Drivers
What determines the business trajectory of Estée Lauder Companies according to management, summarised from the reports up to Q4 FY2026. NadirAlpha methodology
Estée Lauder reported an operating loss of 39 million and a net loss of 116 million in 2026-Q4 against adjusted operating income of 267 million, so the restructuring program expanded in the fiscal 2025 third quarter is central to restoring profitability, 130 29.
Estée Lauder expanded the Profit Recovery and Growth Plan in the fiscal 2025 third quarter, with the earlier Profit Recovery Plan targeted for completion by the end of fiscal 2026; reported operating income has swung between a loss of 390 million in 2025-Q4 and 401 million in 2026-Q2, 29 10.
Fragrance is gaining traction, reported up 10% for FY2026, supported by launches including TOM FORD Oud Voyager and TOM FORD Taormina Orange Eau de Parfum, 30.
Skin Care, the company's largest category by revenue, was reported higher for FY2026 (stated growth 4%), with launches such as La Mer Balancing Infused Emulsion and The Ordinary Caffeine Solution 5% + EGCG Eye Serum, 30.
Estée Lauder reported Mainland China higher for FY2026 (stated growth 9%) and Asia/Pacific higher (stated growth 4%), 30.
Estée Lauder Companies is building distribution on Amazon's U.S. Premium Beauty store, with eleven brands launched as of June 2025 including Aveda, Origins and The Ordinary, and further launches in Amazon.ca, 29 22.
Estée Lauder continued to fund the TOM FORD acquisition, with a deferred consideration payment in fiscal 2026 Q1, while launching new TOM FORD fragrance products, 25 29 30.
Makeup remains a large category for Estée Lauder, with new launches such as M·A·C Skinfinish Lightstruck Liquid Highlighter and M·A·C Skinfinish Colourstruck Blush and a planned entry into select U.S. Sephora locations, 24 30.
Sector trend: Demand across the prestige beauty sector is mixed, with fragrance and parts of Asia improving while overall category growth stays subdued, 30. Profitability is under pressure, as Estée Lauder's reported operating margin swung to losses in several quarters and the company is leaning on restructuring and new distribution channels to rebuild margins, 130 29.
Estée Lauder Companies Revenue by Type (as of 2026-Q4 · USD million · 10/10)
Where the revenue of Estée Lauder Companies comes from: segments and product types with share, growth and margin, as of Q4 FY2026, older structures remain in the expandable part. NadirAlpha methodology
| Segment | Since | Revenue | Growth | Source |
|---|---|---|---|---|
| Period FY2026 (12M) | ||||
| EUKEM | 2025-Q1 | 3,794 | 1% | 30 |
| Mainland China | 2025-Q1 | 3,058 | 9% | 30 |
| Other | FY2023 | 103 | – | 29 |
| Skin Care | 2022-Q3 | 7,338 | 4% | 30 |
| The Americas | 2022-Q3 | 4,463 | 1% | 30 |
| Makeup | 2022-Q3 | 4,276 | – | 30 |
| Asia/Pacific | 2022-Q3 | 3,746 | 4% | 30 |
| Fragrance | 2022-Q3 | 2,779 | 10% | 30 |
| Hair Care | 2022-Q3 | 565 | 1% | 30 |
| Period FY2025 (12M?) | ||||
| Europe, the Middle East & Africa | 2022-Q3 | 5,375 | -13% | 22 |
Estée Lauder Companies Products & announcements (76/112 active+recent)
What Estée Lauder Companies launched, had approved or announced, from the filings up to Q4 FY2026, each row with the date of first mention. NadirAlpha methodology
Status: PlannedLaunched
| Product/Line | Since | Status | Source |
|---|---|---|---|
| 2026 | |||
| M·A·C Skinfinish Colourstruck Blush Launch | 2026-12 | 30 | |
| La Mer Balancing Infused Emulsion launch | 2026-12 | 30 | |
| TOM FORD and other brand.com sites launch | 2026-03 | 28 | |
| TOM FORD Runway Eye Color Quad relaunch | 2026-03 | 28 | |
| M·A·C launch in select Sephora locations (4×) | 2026-03 | 24 | |
| M·A·C Sephora launch | 2026-03 | 26 | |
| Jo Malone London Two Sisters, One Perfect Pear campaign | 2026-03 | 28 | |
| BALMAIN Beauty Destin de Balmain Eau de Parfum | 2026-03 | 28 | |
| Estée Lauder Double Wear next-generation matte innovation launch | 2026-02 | 25 | |
| Clinique and ACUVUE collaboration | 2026-02 | 26 | |
| Bumble and bumble SalonCentric launch | 2026-02 | 26 | |
| TOM FORD freestanding store United Kingdom (2×) | 2026-01 | 28 | |
| M·A·C expansion on Amazon | 2026-01 | 28 | |
| M·A·C Powder Kiss Lip + Cheek Mousse | 2026-01 | 28 | |
| KILIAN PARIS Her Majesty | 2026-01 | 28 | |
| Estée Lauder Revitalizing Supreme+ Sculpting Face Serum | 2026-01 | 28 | |
| The Ordinary targeted expanded consumer reach | 2026 | 29 | |
| TOM FORD new product launches with halo benefits | 2026 | 29 | |
| TOM FORD Soleil Neige launch | 2026 | 30 | |
| TOM FORD Oud Voyager | 2026 | 30 | |
| TOM FORD Figue Érotique launch (3×) | 2026 | 30 | |
| M·A·C Powder Kiss Hazy Matte Lipstick (2×) | 2026 | 28 | |
| Le Labo Violette 30 launch | 2026 | 30 | |
| La Mer Treatment Lotion franchise expansion | 2026 | 29 | |
| KILIAN PARIS Angels' Share on the Rocks launch | 2026 | 30 | |
| KILIAN PARIS Angels' Share and Love, don't be shy franchises | 2026 | 29 | |
| Jo Malone London Beach Blossom Cologne recognition at Fragrance Foundation Awards | 2026 | 30 | |
| Estée Lauder hero product franchises and new product launches | 2026 | 29 | |
| Estée Lauder Double Wear Stay-in-Place Longwear Matte Foundation launch | 2026 | 30 | |
| 14 net new freestanding fragrance stores opened globally (2×) | 2026 | 24 | |
| 2025 | |||
| Jo Malone London AI Scent Advisor | 2025-12 | 26 | |
| Estée Lauder Re-Nutriv Ultimate Lift Rejuvenating Oil | 2025-12 | 26 | |
| The Ordinary Volufiline 92% + Pal-Isoleucine 1% Targeted Plumping Serum | 2025-11 | 28 | |
| TOM FORD solid-to-liquid lip formula and Soleil Neige collection | 2025-11 | 26 | |
| La Mer The New Lip Treatment | 2025-11 | 26 | |
| Lab Series launch on cosme SHOPPING Amazon Japan | 2025-10 | 24 | |
| Global Fragrance Atelier opened in Paris | 2025-10 | 24 | |
| M·A·C Skinfinish Lightstruck Liquid Highlighter | 2025-09 | 24 | |
| Multiple new product launches from La Mer in mainland China and Japan | 2025-09 | 19 | |
| Le Labo Classic Collection new product launches (2×) | 2025-09 | 29 | |
| Estée Lauder Advanced Night Repair Eye Lift + Sculpt Eye Cream | 2025-09 | 24 | |
| The Ordinary Sulfur 10% Powder-to-Cream Concentrate | 2025-08 | 24 | |
| TOM FORD Black Orchid Reserve | 2025-08 | 24 | |
| TOM FORD Architecture Radiance Hydrating Foundation | 2025-08 | 28 | |
| La Mer 'La Mer Gives Skin Life' platform launch | 2025-08 | 24 | |
| M·A·C Lipglazer Glossy Liner | 2025-07 | 24 | |
| Jo Malone London Raspberry Ripple | 2025-07 | 24 | |
| Estée Lauder Re-Nutriv Ultimate Diamond Age Reversal Treatment Lotion | 2025-07 | 24 | |
| KILIAN PARIS event during Cannes Film Festival | 2025-05 | 22 | |
| The Ordinary in Turkey | 2025-04 | 20 | |
| Clinique Moisture Surge Active Glow Serum | 2025-03 | 20 | |
| The Ordinary Multi-Active Delivery Essence | 2025-02 | 20 | |
| The Ordinary Launch in Mainland China | 2025-02 | 18 | |
| Le Labo Eucalyptus 20 | 2025-02 | 20 | |
| Jo Malone London Hand Creams relaunch | 2025-02 | 20 | |
| Beauty Reimagined Strategic Vision | 2025-02 | 29 | |
| The Ordinary Launch in Thailand | 2025-01 | 18 | |
| The Ordinary GF 15% Solution Anti-Aging Serum | 2025-01 | 18 | |
| M·A·C Nudes Collection | 2025-01 | 20 | |
| Estée Lauder Re-Nutriv Longevity Eye Expansion | 2025-01 | 18 | |
| Collaboration with Massachusetts Institute of Technology on Biotechnology Innovations | 2025-01 | 18 | |
| Collaboration with MIT | 2025-01 | 22 | |
| One ELC operating model implementation | 2025 | 29 | |
| M·A·C Lipglass Air, TOM FORD Architecture Soft Matte Blurring Cushion Foundation, The Ordinary UV Filters SPF 45 Serum | 2025 | 22 | |
| Le Labo Eucalyptus 20 and Jo Malone London Hinoki and Cedarwood | 2025 | 22 | |
| La Mer The New Balancing Treatment Lotion, Clinique Almost Lipstick in Nude Honey | 2025 | 22 | |
| La Mer Night Recovery Concentrate (3×) | 2025 | 28 | |
| Fragrance Atelier Location Opening in Paris, France | 2025 | 22 | |
| Estée Lauder Double Wear Stay-in-Place 24-hour Concealer (2×) | 2025 | 20 | |
| 2024 | |||
| Clinique launch on Amazon (9×) | 2024-12 | 24 | |
| MACximal Sleek Satin Lipstick (2×) | 2024-10 | 22 | |
| BALMAIN Beauty launch (4×) | 2024-09 | 29 | |
| Le Labo flagship store in Beijing and Seoul (3×) | 2024 | 22 | |
| 2023 | |||
| The Ordinary on Amazon's U.S. Premium Beauty (29×) | 2023-09 | 29 | |
| Aveda expansion into mainland China (3×) | 2023-03 | 23 | |
| The Ordinary Multi-Peptide Eye Serum launch (4×) | 2023 | 30 | |
| 2024 | |||
| La Mer night-specific consumption entry | 2024-12 | 14 | |
| BioTech Hub opened in Belgium (2×) | 2024-12 | 22 | |
| Clinique CX Advanced Post-Procedure Treatment Franchise for China | 2024-11 | 18 | |
| Talcum litigation settlement agreements with plaintiff law firms | 2024-08 | 15 | |
| Nutritious line of products | 2024-06 | 10 | |
| Le Labo expansion in mainland China, Thailand, Malaysia | 2024-06 | 10 | |
| Le Labo City Exclusives collection | 2024-06 | 10 | |
| Jo Malone London Cologne Intense collection | 2024-06 | 10 | |
| 2023 | |||
| Le Labo launch in mainland China | 2023-12 | 8 | |
| TOM FORD Private Blend Cherry Collection launch | 2023-09 | 4 | |
| The Ordinary new product launches and regional expansion | 2023-06 | 9 | |
| TOM FORD Noir Extreme Parfum launch (2×) | 2023-06 | 4 | |
| M·A·C Powder Kiss Velvet Blur Slim Stick | 2023-06 | 2 | |
| Jo Malone London new product launches | 2023-06 | 9 | |
| Estée Lauder Beautiful Magnolia Intense | 2023-06 | 2 | |
| Clinique new product launches | 2023-06 | 9 | |
| Ultra-Shine Lip Color (TOM FORD) | 2023 | 8 | |
| Too Faced mascara primer | 2023 | 8 | |
| The Ordinary launch in India and Middle East | 2023 | 6 | |
| TOM FORD Café Rose launch (2×) | 2023 | 7 | |
| Soothing & Barrier Support Serum (The Ordinary) | 2023 | 10 | |
| New manufacturing facility near Tokyo | 2023 | 5 | |
| New Research and Development facility in China | 2023 | 5 | |
| M·A·C Studio Radiance Foundation | 2023 | 10 | |
| M·A·C Locked Kiss Ink 24HR Lipcolour | 2023 | 10 | |
| M·A·C Hyper Real line launch (3x) | 2023 | 10 | |
| Manufacturing facility in Japan (5x) | 2023 | 10 | |
| High Impact High-Fi Full Volume Mascara (Clinique) | 2023 | 8 | |
| Distribution center opening in Guangzhou, China | 2023 | 5 | |
| China Innovation Labs | 2023 | 2 | |
| Aveda Launch in Mainland China | 2023 | 6 | |
| Advanced Night Repair Rescue Solution with Bifidus Ferment | 2023 | 10 | |
| Advanced Night Cleansing Balm | 2023 | 10 | |
| 2022 | |||
| Le Labo mainland China launch | 2022-12 | 9 | |
| The Ordinary hair care products launch | 2022-09 | 5 | |
Estée Lauder Companies Transactions & Events (20)
Transactions of Estée Lauder Companies since 2023: acquisitions, disposals, agreements and regulation, deliberately including smaller items; purchase prices only when the company names them. NadirAlpha methodology
Acquisitions by Estée Lauder Companies
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2026 | |||
| 111Skin minority investment | 2026-04 | Completed | 28 |
| Forest Essentials acquisition | 2026-03 | Completed | 28 |
| XINÚ minority stakes announcement (2x) | 2026 | Announced | 30 |
| Forest Essentials remaining interest acquisition | 2026 | Completed | 29 |
| Forest Essentials minority stake acquisition | 2026 | Completed | 30 |
| 2025 | |||
| XINÚ Mexican luxury fragrance brand investment | 2025-11 | Completed | 26 |
| 2024 | |||
| DECIEM remaining interest purchase | 2024-12 | Completed | 13 |
| DECIEM acquisition - remaining interest | 2024-09 | Completed | 12 |
| DECIEM acquisition remaining payment | 2024-05 | Announced | 10 |
| Profit Recovery and Growth Plan expansion (6×) | 2024-02 | Completed | 29 |
| DECIEM Beauty Group remaining interest acquisition | 2024 | Completed | 29 |
| DECIEM Beauty Group acquisition | 2024 | Completed | 21 |
| 2023 | |||
| TOM FORD acquisition (7×) | 2023-04 | Completed | 25 |
| DECIEM investment increase to approximately 76% | 2023 | Completed | 5 |
Divestitures and exits by Estée Lauder Companies
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2024 | |||
| Dr.Jart+ exit from travel retail channel Korea (3×) | 2024-11 | Divested | 20 |
| 2022 | |||
| License terminations of certain designer fragrances effective June 30, 2022 | 2022-06 | Divested | 5 |
| License Terminations - Donna Karan New York, DKNY, Michael Kors, Tommy Hilfiger, Ermenegildo Zegna (3×) | 2022-06 | Divested | 13 |
Partnerships and contracts of Estée Lauder Companies
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2025 | |||
| Shopify Inc. strategic partnership for digital technology modernization | 2025-10 | Agreement | 24 |
| Strategic partnership with Adobe for Firefly generative AI integration | 2025 | Agreement | 22 |
| Jo Malone London partnership with GQ for Men of Year Awards 2024 | 2025 | Agreement | 22 |
Estée Lauder Companies Risks (47 since the annual report of 2026-08-19, 239 tracked in total)
Which risks Estée Lauder Companies has named since the annual report, company-specific first, generic standard risks in the expandable part; first mention refers to the document base from 2023. NadirAlpha methodology
Category: FinancialMacroMarketCustomersLegalCyberESGSupply chainPeopleRegulatoryTechnologyCompetitionGeopolitics
| Risk | Category | Last reported |
|---|---|---|
| Estée Lauder Companies: first mention in 10-K annual report of 2025-08-20 (FY2025), source 21 | ||
| Financial difficulties of retailers could increase credit risk and collections challenges. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 8-K-EX99.1 earnings release of 2026-08-19 (FY2026), source 30 | ||
| Changes in global or local economic conditions including inflation may affect consumer purchasing and operations | = | |
| Shifts in consumer preferences regarding value perception and shopping location may impact sales | = | |
| Estée Lauder Companies: first mention in 10-K annual report of 2026-08-19 (FY2026), source 29 | ||
| Uncertain ability to realize deferred tax assets; valuation allowances could be material if performance declines. | = | |
| Severe adverse impacts on major retail customers could significantly affect business performance. | = | |
| Intellectual property disputes and trademark protection challenges globally. | = | |
| Litigation including asbestos-related claims and product defect claims could result in material losses. | = | |
| Reliance on information technology systems presents risks from system failures and cyber attacks. | = | |
| Global supply chain network optimization focused on sourcing and manufacturing in geography of sale. | = | |
| Inability to achieve announced ESG and sustainability goals could damage brand reputation. | = | |
| Consolidations in retail industry affecting store distribution and receivables collection. | = | |
| Inflationary pressures and tariffs impacting manufacturing costs; excess inventory pressures. | = | |
| Foreign currency exchange rate fluctuations affect business performance and competitive positioning. | = | |
| Middle East conflict impact on travel retail and domestic markets; accounted for approximately 2% of net sales. | = | |
| Change in duty-free retailers servicing Beijing and Shanghai airports creating transitory pressure. | = | |
| Restructuring activities increase risk of employment-related claims and disputes. | = | |
| Government reviews and regulatory investigations could result in fines and operational restrictions. | = | |
| Risks in use of AI including bias, hallucinations, intellectual property infringement and data privacy. | = | |
| Intense competition from multinational manufacturers, indie brands and private equity-backed competitors. | = | |
| Estée Lauder Companies: first mention in 10-Q quarterly report of 2026-05-01 (2026-Q3), source 27 | ||
| Conflict in Middle East had unfavorable impact of 1% on consolidated sales and 2% on EUKEM sales in Q4 2026 | FY2026 2026-08-19 30 | |
| Securities class action settlement agreement in principle reached April 2026 with $84 million loss contingency recorded | FY2026 2026-08-19 30 | |
| Estée Lauder Companies: first mention in 8-K-EX99.1 earnings release of 2026-02-05 (2026-Q2), source 26 | ||
| Talcum litigation settlement agreements for current and potential future cosmetic talcum powder claims through 2029 | = | |
| Estée Lauder Companies: first mention in 8-K-EX99.1 earnings release of 2025-10-30 (2026-Q1), source 24 | ||
| Tariffs anticipated to have adverse effect on fiscal 2027 profitability; potential refunds from IEEPA tariffs. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 10-Q quarterly report of 2025-10-30 (2026-Q1), source 23 | ||
| One Big Beautiful Bill Act enacted with multiple effective dates; uncertain impact on future fiscal years. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 8-K-EX99.1 earnings release of 2025-08-20 (2025-Q4), source 22 | ||
| International emergency economic powers act tariffs of $102 million partially offset by $38 million in refunds received | FY2026 2026-08-19 30 | |
| Estée Lauder Companies: first mention in 10-K annual report of 2025-08-20 (FY2025), source 21 | ||
| GDPR and data privacy regulations create compliance costs and operational constraints. | FY2026 2026-08-19 29 | |
| Inability to anticipate and respond to changing consumer preferences and market trends. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 8-K-EX99.1 earnings release of 2025-02-04 (2025-Q2), source 18 | ||
| Ongoing challenges in key Western markets including Western Europe and United States. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 8-K-EX99.1 earnings release of 2024-10-31 (2024-Q1), source 16 | ||
| Company entered into settlement agreements with plaintiff firms to resolve over 200 pending cosmetic talcum powder matters through December 2029 | FY2026 2026-08-19 30 | |
| Estée Lauder Companies: first mention in 10-Q quarterly report of 2024-10-31 (2025-Q1), source 15 | ||
| Cosmetic talcum powder litigation pending through 2029 with capped annual settlement amounts | 2025-Q3 2025-05-01 20 | |
| Estée Lauder Companies: first mention in 10-K annual report of 2024-08-19 (FY2024), source 13 | ||
| Pillar Two 15% global minimum tax being monitored for potential impacts across jurisdictions. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 8-K-EX99.1 earnings release of 2024-02-05 (2024-Q2), source 10 | ||
| Ability to develop and implement new information technology on timely basis and within cost estimates. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 10-Q quarterly report of 2023-11-01 (2024-Q1), source 7 | ||
| Cybersecurity incidents could compromise consumer and employee data, causing business disruption. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 8-K-EX99.1 earnings release of 2023-08-18 (2023-Q4), source 6 | ||
| Tariffs on imported goods or geopolitical tensions could materially adversely affect business. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 10-K annual report of 2023-08-18 (FY2023), source 5 | ||
| Loss of key executives and senior management could adversely affect business performance. | FY2026 2026-08-19 29 | |
| Securities class action litigation settled in principle for $84 million net of insurance recoveries. | 2026-Q3 2026-05-01 28 | |
| Supply disruptions and single-source material dependencies could impact product availability. | FY2026 2026-08-19 29 | |
| Economic downturns reduce consumer purchases of discretionary beauty products. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 10-Q quarterly report of 2023-05-03 (2023-Q3), source 3 | ||
| Declines in net sales and profitability adversely impacting goodwill and intangible assets, resulting in $861 million impairments in Q2 | 2025-Q2 2025-02-04 18 | |
| Foreign currency fluctuations affect results of operations and value of foreign assets | FY2026 2026-08-19 30 | |
| Changes in laws regarding product ingredients, labeling, marketing and environmental matters. | FY2026 2026-08-19 29 | |
| Estée Lauder Companies: first mention in 8-K-EX99.1 earnings release of 2023-02-02 (2023-Q2), source 2 | ||
| Foreign currency fluctuations affected net sales by approximately $250 million favorably in fiscal 2026. | FY2026 2026-08-19 29 | |
| Increased competitive activity from companies in skin care makeup fragrance and hair care businesses | FY2026 2026-08-19 30 | |
| Estée Lauder Companies: first mention in 10-Q quarterly report of 2023-02-02 (2023-Q2), source 1 | ||
| Disruptions at manufacturing facilities distribution centers or inventory centers may impact operations and increase costs | FY2026 2026-08-19 30 | |
| Retail industry consolidations and bankruptcies may reduce number of stores selling company products | FY2026 2026-08-19 30 | |
| Increased competitive activity in skin care, makeup, fragrance and hair care businesses. | FY2026 2026-08-19 29 | |
| Changes in foreign investment trade policies and regulations of host countries and United States may impact business | FY2026 2026-08-19 30 | |
Estée Lauder Companies Reported KPIs (as disclosed) (136)
The story KPIs of Estée Lauder Companies that standard databases usually miss, grouped by publication, most recent first, with source number. NadirAlpha methodology
| KPI | Value / change | Source |
|---|---|---|
| Estée Lauder Companies, published 2026-08-19, period FY2026 | ||
| total debt to capitalization | 66% | 29 |
| operating margin | 5.2% | 29 |
| operating cash flow | $1,773 | 29 |
| net sales | $15,049 | 29 |
| lauder family voting power percentage | approximately 82% | 29 |
| gross margin | 75.5% | 29 |
| freestanding stores | 1,600 | 29 |
| countries and territories served | approximately 150 | 29 |
| cash and equivalents | $3,498 | 29 |
| Operating Margin | 5.2% | 30 |
| Net cash flows provided by operating activities | 1.77 billion | 30 |
| Gross Margin | 75.5% | 30 |
| Cash and cash equivalents | 3.50 billion | 30 |
| Capital expenditures | 457 million | 30 |
| Adjusted Operating Margin, Non-GAAP | 11.2% | 30 |
| Adjusted Gross Margin, Non-GAAP | 75.5% | 30 |
| Estée Lauder Companies, published 2026-05-01, period 2026-Q3 | ||
| Operating margin | 6.7% | 27 |
| Net sales | 3,712 | 27 |
| Mainland China net sales growth (organic) | 6% | 28 |
| Gross margin | 76.4% | 27 |
| Free Cash Flow | 891 | 28 |
| Fragrance net sales growth (organic) | 10% | 28 |
| Cash and cash equivalents | 3,126 | 27 |
| Estée Lauder Companies, published 2026-02-05, period 2026-Q2 | ||
| Total debt as a percent of total capitalization | 64.5% | 25 |
| Total debt | 7,322 | 25 |
| Net cash flows provided by operating activities | 785 | 26 |
| Gross Margin | 76.5% | 26 |
| Cash and cash equivalents | 3,082 | 25 |
| Capital expenditures | 204 | 26 |
| Adjusted Operating Margin, Non-GAAP | 14.4% | 26 |
| Adjusted Gross Margin, Non-GAAP | 76.5% | 26 |
| Estée Lauder Companies, published 2025-10-30, period 2026-Q1 | ||
| Total debt | 7323 | 23 |
| Cash and cash equivalents | 2219 | 23 |
| Operating Margin | 4.9% | 24 |
| Net cash flows used for operating activities | -340 | 24 |
| Gross Margin | 73.4% | 24 |
| Effective Tax Rate | 56.9% | 24 |
| Capital Expenditures | 96 | 24 |
| Adjusted Operating Margin, Non-GAAP | 7.3% | 24 |
| Adjusted Gross Margin, Non-GAAP | 73.3% | 24 |
| Adjusted Effective Tax Rate, Non-GAAP | 40.5% | 24 |
| Estée Lauder Companies, published 2025-08-20, period FY2025 | ||
| Total debt as percent of total capitalization | 65% | 21 |
| Lauder family voting power | approximately 84% | 21 |
| Freestanding stores | approximately 1,600 | 21 |
| Demonstrators at points of sale | approximately 35,000 | 21 |
| Countries with wholly-owned operations | over 50 | 21 |
| Countries with online sites | approximately 50 | 21 |
| Countries and territories with presence | approximately 150 | 21 |
| Cash and cash equivalents | 2,921 | 21 |
| Estée Lauder Companies, published 2025-08-20, period 2025-Q4 | ||
| Tariff-related profitability impact | 100 million | 22 |
| Restructuring program cumulative charges | 747 million | 22 |
| Quarterly dividend per share | .35 | 22 |
| Net reduction in positions | 5,800 to 7,000 | 22 |
| Estée Lauder Companies, published 2025-05-01, period 2025-Q3 | ||
| Quarterly Dividend Per Share | .35 | 20 |
| Operating Income | 306 | 20 |
| Net Cash Flows from Operating Activities | 671 | 20 |
| Dividends Paid | (492) | 20 |
| Capital Expenditures | (395) | 20 |
| Estée Lauder Companies, published 2025-02-04, period 2025-Q2 | ||
| Total debt | 7280 | 17 |
| Impairment charge Tom Ford other | 54 | 17 |
| Impairment charge Tom Ford makeup | 170 | 17 |
| Impairment charge Tom Ford fragrance | 549 | 17 |
| Adjusted Operating Margin, Non-GAAP (Q2) | 11.5% | 18 |
| Adjusted Operating Margin, Non-GAAP (H1) | 8.2% | 18 |
| Adjusted Gross Margin, Non-GAAP | 76.1% | 18 |
| Estée Lauder Companies, published 2024-10-31, period 2025-Q1 | ||
| total debt as % of capitalization prior period | 59% | 15 |
| total debt as % of capitalization | 61% | 15 |
| operating margin prior year | 2.8% | 15 |
| operating margin | (3.6)% | 15 |
| gross margin prior year | 69.6% | 15 |
| gross margin | 72.4% | 15 |
| effective tax rate prior year | 21.7% | 15 |
| effective tax rate | 13.3% | 15 |
| Estée Lauder Companies, published 2024-10-31, period 2024-Q1 | ||
| Organic net sales growth | (5%) | 16 |
| Operating cash flow | -670 | 16 |
| Gross margin | 72.4% | 16 |
| Dividend per share | .35 | 16 |
| Cash and cash equivalents | 2,350 | 16 |
| Capital expenditures | 141 | 16 |
| Estée Lauder Companies, published 2024-08-19, period FY2024 | ||
| total debt % of capitalization | 59% | 13 |
| multi-branded company stores | over 300 | 13 |
| Lauder family voting power | approximately 84% | 13 |
| interest expense | 378 | 13 |
| interest and investment income net | 167 | 13 |
| freestanding stores | approximately 1,600 | 13 |
| countries with online sales sites | approximately 50 | 13 |
| Cash and cash equivalents | 3,395 | 13 |
| Estée Lauder Companies, published 2024-08-19, period 2024-Q4 | ||
| Organic net sales growth | (2%) | 14 |
| Operating cash flow | $2.36 billion | 14 |
| Dividends paid | $0.95 billion | 14 |
| Cash and cash equivalents | $3.40 billion | 14 |
| Capital expenditures | $0.92 billion | 14 |
| Estée Lauder Companies, published 2024-05-01, period 2024-Q3 | ||
| Total debt | 7,770 | 11 |
| net cash flows from operating activities 9M | 1,471 | 11 |
| net cash flows from operating activities 9M | 1,017 | 11 |
| Cash and cash equivalents | 3,701 | 11 |
| Reported Operating Income - Q3 | $531 million | 12 |
| Reported Net Sales - Q3 | $3.94 billion | 12 |
| Organic Net Sales Growth - Q3 | 6% | 12 |
| Operating Income Margin - Q3 | 13.5% | 12 |
| Operating Cash Flow | $1.47 billion | 12 |
| Net Earnings | $695 million | 12 |
| Gross Margin - Q3 | 71.9% | 12 |
| Dividends Paid | $0.71 billion | 12 |
| Cash and Cash Equivalents | $3.70 billion | 12 |
| Adjusted Operating Income - Q3 | $554 million | 12 |
| Estée Lauder Companies, published 2024-02-05, period 2024-Q2 | ||
| Total debt | 8,140 | 9 |
| Total debt | 8,140 | 10 |
| Property, plant and equipment, net | 3,220 | 10 |
| Operating lease right-of-use assets | 1,819 | 10 |
| Operating income margin | 13.4% | 10 |
| Operating expense margin | 59.6% | 10 |
| Net cash flows from operating activities | 937 | 10 |
| Long-term debt | 6,640 | 10 |
| Gross margin | 73.0% | 10 |
| Effective tax rate | 37.6% | 10 |
| Dividends paid | 474 | 10 |
| Current debt | 1,500 | 10 |
| Cash and cash equivalents | 3,939 | 10 |
| Capital expenditures | 527 | 10 |
| Estée Lauder Companies, published 2023-11-01, period 2024-Q1 | ||
| Organic Net Sales | -11% | 8 |
| Operating margin | 2.8% | 7 |
| Operating income margin | 2.8% | 8 |
| Operating income | 98 million | 8 |
| Net sales | 3,518 million | 8 |
| Net cash flows used for operating activities | -408 million | 8 |
| Gross margin | 69.6% | 7 |
| Gross margin | 69.6% | 8 |
| Effective tax rate | 21.7% | 7 |
| Dividends paid | 236 million | 8 |
| Diluted EPS (GAAP) | $.09 | 8 |
| Cash and cash equivalents | 3,090 million | 8 |
| Capital Expenditures | 295 million | 8 |
| Adjusted Operating Income (Non-GAAP) | 108 million | 8 |
| Adjusted Diluted EPS | $.11 | 8 |
| Adjusted Constant Currency EPS | $.12 | 8 |
Estée Lauder Companies Development
The business development of Estée Lauder Companies period by period up to Q4 FY2026, each text from the original report of that period, source numbers lead to the source. NadirAlpha methodology
FY2026: Estée Lauder Companies
Estée Lauder generated full-year net sales of USD 15,049 million in fiscal 2026, an increase of 5% from fiscal 2025 driven by volume growth of 2%, favorable foreign currency translation of 2%, and pricing increases of 1% 29. Operating income recovered to USD 780 million compared to an operating loss of $785 million in fiscal 2025, primarily reflecting a favorable comparison to prior-year impairment charges and increased sales 29. Gross margin expanded 150 basis points to 75.5% and free cash flow improved to USD 1,316 million, both supported by benefits from the Profit Recovery and Growth Plan 29 30. For fiscal 2027, the company affirmed organic net sales growth of 3% to 5% and raised adjusted operating margin guidance to a range of 12.7% to 13.5% 30.
FY2025: Estée Lauder Companies
Estée Lauder recorded full-year revenue of USD 14,326 million in fiscal 2025, down 8% from the prior year, as a 10% volume decline across all product categories and geographic regions was only partially offset by a 2% pricing increase, with Asia/Pacific and travel retail under particular pressure 21. Estée Lauder Companies swung to an operating loss of USD 785 million from operating income of $970 million in fiscal 2024, driven by $1,286 million in goodwill and intangible asset impairments including $773 million on the TOM FORD trademark and $375 million on Dr.Jart+ assets 21. Gross margin improved 230 basis points to 74.0%, supported by cost efficiencies and lower obsolescence charges from the Profit Recovery and Growth Plan, though operating cash flow fell to USD 1,272 million from $2,360 million in fiscal 2024 21. In February 2025, Estée Lauder launched its Beauty Reimagined strategic vision and expanded the Profit Recovery and Growth Plan to target 5,800 to 7,000 position reductions representing 9 to 11% of the global workforce, with expected annual gross benefits of $800 million to $1,000 million 21.
FY2024: Estée Lauder Companies
Estée Lauder Companies reported full-year fiscal 2024 net sales of 15,608 million, with net sales decreasing 2% primarily from lower skin care sales driven by softness in mainland China and the Asia travel retail business 13. Operating income declined to 970 million, significantly impacted by $471 million in goodwill and intangible asset impairments related to the Dr.Jart+ reporting unit, which had shifted strategy to exit travel retail 13. Full-year diluted EPS declined 61% to 1.08 per share, while adjusted diluted EPS was 2.59 per share 13 14. Estée Lauder launched the Profit Recovery and Growth Plan targeting $1.1 to $1.4 billion in operating profit net savings through fiscal years 2025 and 2026, alongside a restructuring program targeting 1,800 to 3,000 position reductions globally 13. Operating cash flow improved to 2,360 million, driven by favorable working capital changes, and the company completed the full acquisition of DECIEM Beauty Group Inc. for $859 million in May 2024 13.
FY2023: Estée Lauder Companies
Estée Lauder Companies posted full-year net sales of 15,910 million in fiscal 2023, a decrease of 10% on a reported basis and 7% in constant currency, driven by a slower-than-expected recovery in Asia travel retail and mainland China, pandemic-related restrictions, a stronger U.S. dollar, and global inflationary pressures 5. Gross margin declined 440 basis points to 71.3%, reflecting unfavorable product mix, higher manufacturing costs, and obsolescence charges, while operating income reached 1,509 million; the year also included $207 million in trademark impairment charges for Dr.Jart+, Too Faced, and Smashbox 5. Diluted EPS decreased 57% to 2.79 6. Estée Lauder completed the acquisition of the TOM FORD brand on April 28, 2023, and disclosed a cybersecurity incident in July 2023 involving unauthorized third-party access to some systems and consumer data 5. The fourth quarter returned to growth, with net sales of 3,609 million up 1% reported and 4% organic, while Fragrance achieved double-digit growth across every region 6.
Glossary
- Revenue: Revenue from contracts with customers, net of sales deductions, as the company itself reports it; not total output, gross revenue, GMV or order intake.
- Op. income: The operating line of the income statement; EBIT only as a marked fallback, never pre-tax or ordinary income.
- Op. income (adj.): Adjusted operating income, verbatim and company-defined (non-GAAP), never derived.
- Net income: Net income attributable to the shareholders of the parent, after discontinued operations; not the result including minority interests, not comprehensive income.
- EPS: Diluted earnings per share attributable to the shareholders of the parent; a printed figure always beats a calculated one, calculated values are marked.
- EPS adj.: Adjusted earnings per share, verbatim and company-defined (non-GAAP).
- FCF: Free cash flow = operating cash flow minus capital expenditure on property, plant and equipment; the company's own free cash flow figure is shown separately.
- OCF: Cash flow from operating activities as reported; IFRS companies may show interest paid in financing cash flow, so the figure is not always comparable.
- Cash: Cash and cash equivalents, without securities unless the company reports them as part of the position.
- Net Debt: Net debt = financial debt excluding lease liabilities minus cash at the same reporting date; the company's own net position may differ.
- *: derived, the formula is in the hover
- ≈: calculated, approximation
- ~: uncertain; the value stays visible, verdicts do not use it
- °: repaired by a targeted query against the document, or curated with documentary evidence
- EBIT: EBIT as a fallback: the income statement carries no operating line
- basic: basic earnings per share as a fallback when diluted is missing
Sources: quarterly reports, annual reports and investor relations documents
The evidence base for Estée Lauder Companies stock: every document with type and date, every figure in the report leads here by number and to the original by link. NadirAlpha methodology
Older sources (+18)
| # | Document type | Published |
|---|---|---|
| #211 | 10-K annual report | 2016-05-03 |
| #215 | 10-K annual report | 2016-08-24 |
| #213 | 10-Q quarterly report | 2017-02-02 |
| #212 | 10-Q quarterly report | 2017-11-01 |
| #216 | 10-Q quarterly report | 2018-02-02 |
| #217 | 10-K annual report | 2018-02-02 |
| #214 | 10-Q quarterly report | 2018-05-02 |
| #201 | 10-K annual report | 2018-08-24 |
| #218 | 10-Q quarterly report | 2019-02-05 |
| #205 | 10-K annual report | 2019-08-23 |
| #209 | 10-K annual report | 2019-08-23 |
| #202 | 10-Q quarterly report | 2019-10-31 |
| #203 | 10-Q quarterly report | 2020-02-06 |
| #204 | 10-Q quarterly report | 2020-05-01 |
| #206 | 10-Q quarterly report | 2020-11-02 |
| #207 | 10-Q quarterly report | 2021-02-05 |
| #208 | 10-Q quarterly report | 2021-05-03 |
| #210 | 10-Q quarterly report | 2021-11-02 |
Estée Lauder Companies Stock FAQ
Is there a management forecast (guidance) for FY2027?
Yes. Management has issued targets for FY2027, including Tax rate. The guidance tracking chapter shows all targets and checks them against the actuals reported later; neutral, with no estimate of our own.
Does Estée Lauder Companies pay a dividend?
The filings report on the dividend; most recent entry: dividend per share .35 (2025-Q4) (as reported, no assessment of our own). Details with source links are in the report chapters.
Where can I find the official investor relations documents of Estée Lauder Companies?
NadirAlpha links all 48 original filings used (SEC filings) in the sources chapter: earnings release, quarterly report, annual report, each with type, publication date and a direct link; every figure in the report carries a source number.